Compare UTHR & NVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | NVR |
|---|---|---|
| Founded | 1996 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9B | 21.8B |
| IPO Year | 1999 | 1995 |
| Metric | UTHR | NVR |
|---|---|---|
| Price | $531.38 | $6,485.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | $531.79 | ★ $8,112.50 |
| AVG Volume (30 Days) | ★ 477.5K | 17.4K |
| Earning Date | 04-29-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.07 | N/A |
| EPS | 27.86 | ★ 436.55 |
| Revenue | $1,483,300,000.00 | ★ $10,323,959,000.00 |
| Revenue This Year | $7.77 | N/A |
| Revenue Next Year | $11.11 | $7.02 |
| P/E Ratio | $19.04 | ★ $14.82 |
| Revenue Growth | ★ 2.38 | N/A |
| 52 Week Low | $266.98 | $6,368.70 |
| 52 Week High | $548.12 | $8,618.28 |
| Indicator | UTHR | NVR |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 27.85 |
| Support Level | $464.92 | N/A |
| Resistance Level | $542.66 | $7,751.09 |
| Average True Range (ATR) | 14.71 | 158.99 |
| MACD | 2.68 | -59.63 |
| Stochastic Oscillator | 76.95 | 8.37 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.
NVR Inc is a United States-based homebuilding company. It builds single-family detached homes, townhomes, and condominium buildings under three brands, Ryan Homes, NVHomes, and Heartland Homes. The company through its subsidiary also operates a mortgage banking and title services business. The homebuilding segment includes four geographic areas of the Mid-Atlantic, North East, Mid-East, and South East.